SCHEMBL7673071

SCHEMBL7673071

CNS(=O)(=O)c1ccc(C=[N+](C)[O-])o1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 2/20 0.38
CA1 P00915 2/20 0.38
CA2 P00918 2/20 0.38
CA3 P07451 2/20 0.38
CA4 P22748 2/20 0.38
CA6 P23280 2/20 0.38
CA5A P35218 2/20 0.38
CA7 P43166 2/20 0.38
CA9 Q16790 2/20 0.38
CA13 Q8N1Q1 2/20 0.38
CA14 Q9ULX7 2/20 0.38
CA5B Q9Y2D0 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.34
GAA P10253 1/20 0.34
MEN1 O00255 3/20 0.33
KMT2A Q03164 3/20 0.33
POLB P06746 2/20 0.33
G6PD P11413 1/20 0.33
VCAM1 P19320 1/20 0.33
HTT P42858 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7671014 0.83 ALDH1A1 (0.36) CA12CA1CA2CA3CA4
SCHEMBL7664608 0.83 CA12 (0.35) CA12CA1CA2CA3CA4
SCHEMBL7667410 0.83 CA12 (0.35) CA12CA1CA2CA3CA4
SCHEMBL7669753 0.81 CA12 (0.33) CA12CA1CA2CA3CA4
SCHEMBL7666039 0.80 CA1 (0.43) CA1CA2MEN1KMT2AKDM4E
SCHEMBL7665563 0.80 CA12 (0.33) CA12CA1CA2CA3CA4
SCHEMBL7667780 0.79 HTT (0.32) CA12CA1CA2CA3CA4
SCHEMBL7667556 0.79 CA12 (0.32) CA12CA1CA2CA3CA4
SCHEMBL8185842 0.79 CA1 (0.39) CA12CA1CA2CA3CA4
SCHEMBL7658917 0.78 CASP6 (0.42) CA12CA1CA2CA3CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376540-B1 PREVENT NEURODEGENERATIVE DISEASE CENTAUR PHARMACEUTICALS, INC. 2002-04-23 US disclosed
US-6051571-A NERVOUS SYSTEM DISORDERS; CARDIOVASCULAR DISORDERS CENTAUR PHARMACEUTICALS, INC. (US) 2000-04-18 US disclosed
US-6040444-A Process for preparing furan nitrone compounds CENTAUR PHARMACEUTICALS, INC. (US) 2000-03-21 US disclosed